SynthesisFrontiers in oncology2026
Suicide risk and mortality among patients with cancers of the digestive system: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although significant strides have been made in cancer therapy, studies show that suicide rates among digestive cancer patients compared to the general population remain controversial, and specific risk factors are not clearly defined. Therefore, we conducted a systematic review and meta-analysis of the standardized mortality ratios (SMRs) in patients with digestive system cancer. Methods: PubMed, Embase, Web of Science and Cochran Library databases were searched for relevant articles up to June 2025. We assessed SMRs by cancer type, sex, cancer prognosis, time since diagnosis, geographic region and year of recruitment. We performed meta-analysis by random effects model and evaluated heterogeneity using I² statistic. Publication bias was performed by funnel plots, Edger's and B egg's tests. Results: 12 cohort studies comprising 6763452 digestive cancer patients were eligible. The total SMR in this population was (SMR = 2.25, 95% CI = 1.89-2.66, P < 0.000). The SMRs were significantly increased for esophageal (SMR = 3.35, 95% CI = 2.37-4.75, P < 0.000), pancreatic (SMR = 3.87, 95% CI = 2.33-6.41, P < 0.000), stomach (SMR = 2.10, 95% CI = 1.81-2.43, P < 0.000), liver (SMR = 1.89, 95% CI = 1.38-2.59, P = 0.066) and colorectum (SMR = 1.57, 95% CI = 1.36-1.81, P < 0.000) cancers. Furthermore, the SMRs exhibit significant variations influenced by other contributing factors. Conclusions: Due to various suicide risk factors, the SMRs among digestive cancer patients surpasses that of the general population by more than double. Hence, heightened psychological support is warranted for these patients. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261288056, identifier CRD420261288056.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.